Loading...
Loading...
Browse all stories on DeepNewz
VisitWhat will be the stock price of Element Biosciences by the end of 2024?
Below $50 • 25%
$50-$100 • 25%
$100-$150 • 25%
Above $150 • 25%
Stock market data from financial news outlets and stock exchanges
Element Biosciences Raises $277 Million in Series D Venture Funding
Jul 12, 2024, 01:13 PM
Element Biosciences, a San Diego-based company specializing in next-generation sequencing (NGS), has successfully raised $277 million in a Series D venture funding round. The investment will enable the company to continue commercializing its AVITI benchtop genomic analyzer and launch its next product, AVITI24. This significant funding round positions Element Biosciences as a formidable competitor to Illumina in the DNA sequencing market. The company aims to leverage this capital to solidify its presence and drive rapid growth in the biotechnology sector.
View original story
Below $0.50 • 25%
$0.50 - $0.99 • 25%
$1.00 - $1.49 • 25%
$1.50 and above • 25%
Increase by more than 10% • 25%
Increase by less than 10% • 25%
Decrease by less than 10% • 25%
Decrease by more than 10% • 25%
Above $25 • 25%
Between $20 and $25 • 25%
Between $15 and $20 • 25%
Below $15 • 25%
Less than $1 • 25%
$1 to $2 • 25%
$2 to $3 • 25%
More than $3 • 25%
Above 50% increase • 25%
10% to 50% increase • 25%
0% to 10% increase • 25%
Decrease • 25%
Decrease by more than 20% • 25%
Decrease by less than 20% • 25%
Increase by less than 20% • 25%
Increase by more than 20% • 25%
Decrease by more than 10% • 25%
Change between -10% and 10% • 25%
Increase by 10% to 20% • 25%
Increase by more than 20% • 25%
Above $20 • 25%
$15 to $20 • 25%
$10 to $15 • 25%
Below $10 • 25%
Below $20 • 25%
$20 to $30 • 25%
$30 to $40 • 25%
Above $40 • 25%
Decrease by 5% or more • 25%
Change between -5% and 5% • 25%
Increase between 5% and 10% • 25%
Increase by 10% or more • 25%
Stock increases by 10% or more • 25%
Stock remains within +/- 10% • 25%
Stock decreases by 10% or more • 25%
Stock remains volatile with no clear trend • 25%
No • 50%
Yes • 50%
None • 25%
Three or more • 25%
Two • 25%
One • 25%